广济药业: Yan kuruluş Guanghua Pharmaceutical, sermaye artırımı ve hissedarların dahil edilmesi için genişlemeyi planlıyor.

Jinshi Data News on November 15th, Guangji Pharmaceutical announced in the evening that its wholly-owned subsidiary, Hubei Guanghua Pharmaceutical Co., Ltd. intends to be pre-listed on the Shanghai United Equity Exchange borsa and introduce strategic investors through capital increase and share expansion. The counterparty of this transaction is not yet determined, and it is currently impossible to determine whether it constitutes a related party transaction. The final shareholding ratio, capital increase amount, and other content are currently uncertain.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)